A Message From the Editor-in-Chief Dear Colleagues, The March issue of the Journal of Drugs in Dermatology highlights a diverse range of topics that reflect our specialty's dynamic and evolving…
Read More
Intralesional Steroids vs. Cryotherapy: Which Wins for Alopecia Areata? Alopecia Areata (AA) remains an enigmatic condition with treatment options offering varying degrees of success. While intralesional corticosteroids are the first-line treatment,…
Read More
Hyaluronidase and HA Fillers: Does One Dose Fit All? Not all HA fillers dissolve the same way. A new study reveals that HA concentration is key in determining hyaluronidase effectiveness,…
Read More
Trending Article We know cold weather dries out skin, but did you know it can also cause full-blown medical conditions? Cold temperatures compromise the skin’s barrier, triggering inflammation, water loss,…
Read More
Access Denied: Medicaid’s Barrier to Dermatologic Treatment Vitiligo and alopecia areata (AA) are not just cosmetic concerns—they profoundly affect patients' quality of life. While the FDA has approved innovative JAK inhibitors…
Read More
Patchy Hair Loss: When Alopecia Areata Isn’t the Answer Not all patchy hair loss is alopecia areata. Two recent cases reveal cutaneous lupus erythematosus (CLE) mimicking AA, highlighting a critical…
Read More
Sonidegib for laBCC: A Neoadjuvant Game Changer? Neoadjuvant Hedgehog Pathway Inhibitors (HPIs) are reshaping the approach to locally advanced basal cell carcinoma (laBCC), but tolerability remains a concern. A recent…
Read More
Featured Case Report Could your patient’s go-to antiseptic be sabotaging sperm quality? PVP-I (povidone-iodine) is a trusted antimicrobial, but a recent case raises concerns about its impact on male fertility.…
Read More
A Spotlight on Skin Health As February unfolds, so does an important reminder—this month is National Cancer Prevention Month. For dermatologists, it’s a time to reinforce awareness, education, and proactive…
Read More
JDD Spotlight: A Novel Topical Approach for Seborrheic Keratoses? Could a new topical formula change the way we manage seborrheic keratoses? In a pilot study, a unique blend of antioxidants,…
Read More
JDD Spotlight: Guselkumab’s 5-Year Promise in Psoriasis Curious about long-term breakthroughs in psoriasis care? A recent pooled analysis from the Phase 3 VOYAGE studies hints that guselkumab might be a…
Read More
Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups
JDD Spotlight: Dupilumab Shows Rapid, Sustained Relief for Lichenification in AD A new pooled analysis from five clinical trials has revealed that dupilumab significantly improves lichenification in moderate to severe…
Read More
